Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > News > Big Pharma Is Missing the Nanotechnology Opportunity

February 15th, 2005

Big Pharma Is Missing the Nanotechnology Opportunity

Abstract:
The U.S. National Institutes of Health counts nanomedicine as one of its top five priorities, the National Cancer Institute committed $144 million to nanotechnology research in October 2004, and 40% of nanotech venture capital since 1998 has gone to life sciences start-ups. Yet despite nanotechnology's promise in improving how drugs are developed and delivered, major pharmaceutical companies are committing almost
no money or people to nanotechnology research -- exposing them to strategic
risks, according to a new report from Lux Research entitled "Why Big Pharma Is
Missing the Nanotech Opportunity."

Source:
prnewswire

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

A new technique to make drugs more soluble August 28th, 2015

These microscopic fish are 3-D-printed to do more than swim: Researchers demonstrate a novel method to build microscopic robots with complex shapes and functionalities August 26th, 2015

Glitter from silver lights up Alzheimer's dark secrets August 25th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic